BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20886217)

  • 1. The armadillo repeat domain of Apc suppresses intestinal tumorigenesis.
    Crist RC; Roth JJ; Baran AA; McEntee BJ; Siracusa LD; Buchberg AM
    Mamm Genome; 2010 Oct; 21(9-10):450-7. PubMed ID: 20886217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-species comparison of human and mouse intestinal polyps reveals conserved mechanisms in adenomatous polyposis coli (APC)-driven tumorigenesis.
    Gaspar C; Cardoso J; Franken P; Molenaar L; Morreau H; Möslein G; Sampson J; Boer JM; de Menezes RX; Fodde R
    Am J Pathol; 2008 May; 172(5):1363-80. PubMed ID: 18403596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenomatous polyposis coli (APC) membrane recruitment 3, a member of the APC membrane recruitment family of APC-binding proteins, is a positive regulator of Wnt-β-catenin signalling.
    Brauburger K; Akyildiz S; Ruppert JG; Graeb M; Bernkopf DB; Hadjihannas MV; Behrens J
    FEBS J; 2014 Feb; 281(3):787-801. PubMed ID: 24251807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis.
    Gaspar C; Franken P; Molenaar L; Breukel C; van der Valk M; Smits R; Fodde R
    PLoS Genet; 2009 Jul; 5(7):e1000547. PubMed ID: 19578404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
    Li Q; Ishikawa TO; Oshima M; Taketo MM
    Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Truncated Adenomatous Polyposis Coli Mutation Induces Asef-Activated Golgi Fragmentation.
    Kim SB; Zhang L; Yoon J; Lee J; Min J; Li W; Grishin NV; Moon YA; Wright WE; Shay JW
    Mol Cell Biol; 2018 Sep; 38(17):. PubMed ID: 29866653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the armadillo repeat domain of adenomatous polyposis coli which reveals its inherent flexibility.
    Zhang Z; Lin K; Gao L; Chen L; Shi X; Wu G
    Biochem Biophys Res Commun; 2011 Sep; 412(4):732-6. PubMed ID: 21871439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade.
    Albuquerque C; Breukel C; van der Luijt R; Fidalgo P; Lage P; Slors FJ; Leitão CN; Fodde R; Smits R
    Hum Mol Genet; 2002 Jun; 11(13):1549-60. PubMed ID: 12045208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APC mutations in colorectal tumours from FAP patients are selected for CtBP-mediated oligomerization of truncated APC.
    Schneikert J; Brauburger K; Behrens J
    Hum Mol Genet; 2011 Sep; 20(18):3554-64. PubMed ID: 21665989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel read through agent: ZKN-0013 demonstrates efficacy in APC
    Graf MR; Apte S; Terzo E; Padhye S; Shi S; Cox MK; Clark RB; Modur V; Badarinarayana V
    J Mol Med (Berl); 2023 Apr; 101(4):375-385. PubMed ID: 36808265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A knock-in mouse model reveals roles for nuclear Apc in cell proliferation, Wnt signal inhibition and tumor suppression.
    Zeineldin M; Cunningham J; McGuinness W; Alltizer P; Cowley B; Blanchat B; Xu W; Pinson D; Neufeld KL
    Oncogene; 2012 May; 31(19):2423-37. PubMed ID: 21996741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haploinsufficiency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis.
    Ghaleb AM; McConnell BB; Nandan MO; Katz JP; Kaestner KH; Yang VW
    Cancer Res; 2007 Aug; 67(15):7147-54. PubMed ID: 17671182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients.
    Crabtree M; Sieber OM; Lipton L; Hodgson SV; Lamlum H; Thomas HJ; Neale K; Phillips RK; Heinimann K; Tomlinson IP
    Oncogene; 2003 Jul; 22(27):4257-65. PubMed ID: 12833148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. different Roles for the axin interactions with the SAMP versus the second twenty amino acid repeat of adenomatous polyposis coli.
    Schneikert J; Ruppert JG; Behrens J; Wenzel EM
    PLoS One; 2014; 9(4):e94413. PubMed ID: 24722208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian steroid cell tumor with biallelic adenomatous polyposis coli inactivation in a patient with familial adenomatous polyposis.
    Hu PJ; Knoepp SM; Wu R; Cho KR
    Genes Chromosomes Cancer; 2012 Mar; 51(3):283-9. PubMed ID: 22120905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The armadillo repeat domain of the APC tumor suppressor protein interacts with Striatin family members.
    Breitman M; Zilberberg A; Caspi M; Rosin-Arbesfeld R
    Biochim Biophys Acta; 2008 Oct; 1783(10):1792-802. PubMed ID: 18502210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational screening through comprehensive bioinformatics analysis to detect novel germline mutations in the APC gene in patients with familial adenomatous polyposis (FAP).
    Ghadamyari F; Heidari MM; Zeinali S; Khatami M; Merat S; Bagherian H; Rejali L; Ghasemi F
    J Clin Lab Anal; 2021 May; 35(5):e23768. PubMed ID: 33769591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis.
    Groves C; Lamlum H; Crabtree M; Williamson J; Taylor C; Bass S; Cuthbert-Heavens D; Hodgson S; Phillips R; Tomlinson I
    Am J Pathol; 2002 Jun; 160(6):2055-61. PubMed ID: 12057910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding phenotypic variation in rodent models with germline Apc mutations.
    Zeineldin M; Neufeld KL
    Cancer Res; 2013 Apr; 73(8):2389-99. PubMed ID: 23580574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours.
    Kohler EM; Chandra SH; Behrens J; Schneikert J
    Hum Mol Genet; 2009 Jan; 18(2):213-26. PubMed ID: 18854359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.